Lung Screening for Lung Cancer

Recruiting at 10 trial locations

Overseen By Francis Valenzona

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Hackensack Meridian Health

Disqualifiers: Lung cancer, Prior lung screening, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Approved in 1 Jurisdiction This treatment is already approved in other countries

Compensation: Varies

Number of Visits: 2

100 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The trial aims to increase lung cancer screening using a tailored educational tool called LungTalk. LungTalk is an interactive program delivered via iPad that adjusts its content based on smoking status and perceived barriers to screening. Researchers will compare participants using LungTalk to another group receiving a standard lung screening pamphlet to determine which method more effectively boosts screening rates. The trial seeks individuals who are current or former smokers, aged 50 to 80, with a significant smoking history and who have never been screened for lung cancer. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve lung cancer screening methods.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the LungTalk Digital Tool is safe for use in lung cancer screening?

Research has shown that LungTalk, a computer-based learning tool, received positive feedback in past studies. In earlier trials, LungTalk doubled participants' knowledge about lung cancer screening and improved their health beliefs without causing major side effects. Participants who used LungTalk were significantly more likely to choose lung cancer screening than those who did not use it. This suggests that LungTalk is safe and effective in promoting lung cancer screening. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about LungTalk because it offers a personalized and interactive approach to learning about lung cancer screening. Unlike standard educational brochures that provide generic information, LungTalk tailors its content to the individual's smoking status and perceived barriers, making the information more relevant and engaging. By using a mix of audio, video, and animations delivered through an iPad, LungTalk adapts to different learning preferences, which has been shown to significantly boost knowledge and influence decisions about screening. This innovative approach could lead to more people choosing to undergo lung cancer screening, ultimately improving early detection rates.

What evidence suggests that the LungTalk tool is effective for increasing lung screening uptake?

Research has shown that LungTalk, an interactive educational tool, may help increase lung cancer screening rates. In this trial, participants in the LungTalk Group will use this tool, which earlier studies found more than doubled participants' understanding and beliefs about lung cancer screening. It also significantly increased the number of people deciding to get screened, with nearly twice as many choosing screening compared to those who used a standard pamphlet. LungTalk provides information tailored to a person's smoking habits and concerns, addressing personal worries and encouraging more people to get screened. These findings suggest that LungTalk could effectively promote lung cancer screening. ^{3 5 6 7 8}

Who Is on the Research Team?

Lisa Carter-Bawa, PhD

Principal Investigator

Hackensack Meridian Health

Are You a Good Fit for This Trial?

The LEAD Study is for individuals aged 50-80 who have a history of heavy smoking (at least 20 pack-years), are current smokers or quit within the last 15 years, and have never had lung cancer screening. Participants must be able to give informed consent and speak English.

Inclusion Criteria

I currently smoke or quit smoking within the last 15 years.

I can speak and understand English.

I am between 50 and 80 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a tailored lung screening intervention using the LungTalk tool or a non-tailored pamphlet

1 month

1 visit (in-person) for intervention delivery

Follow-up

Participants are monitored for changes in lung cancer screening uptake and related health beliefs

6 months

Assessments at 1 week, 1 month, and 6 months post-intervention

What Are the Treatments Tested in This Trial?

Interventions

• LungTalk

Trial Overview

This study tests 'LungTalk', a tailored intervention to increase lung screening uptake, against non-tailored lung screening advice in the Emergency Department. It aims to see if personalized communication can improve knowledge and attitudes towards lung cancer screening.

How Is the Trial Designed?

Group I: LungTalk Group Experimental Treatment 1 Intervention

LungTalk is a novel theoretically grounded health educational tool that will be delivered via iPad and is an interactive computer-based program that includes audio, video and animation segments with scripts presented from a master content library in consideration of different ways people like to learn. Informed by our prior research, LungTalk tailors its content based on smoking status and perceived barriers. In prior work, LungTalk more than doubled Lung Cancer Screening (LCS) knowledge and health beliefs (p \< 0.01), and was associated with a significant increase in deciding to screen for lung cancer compared to control group; OR 1.99; 95% CI, 1.03, 3.85, p = 0.03.

Group II: Non-tailored Lung Screening Pamphlet Group Active Control 1 Intervention

Non-tailored Lung Screening Pamphlet is a non-tailored educational brochure, What is Lung Cancer Screening from the GO2 Foundation that will be emailed to the patient. This widely used educational standard of care is a 2-page reader-friendly non-tailored electronic brochure about risk and screening for lung cancer used in clinical and community settings.

LungTalk is already approved in United States for the following indications:

Approved in United States as LungTalk for:

• Lung Cancer Screening Awareness
• Education and Support

Who Is Running the Clinical Trial?

Hackensack Meridian Health

Lead Sponsor

Trials

141

Recruited

42,900+

New Jersey Commission on Cancer Research

Collaborator

Trials

1

Recruited

100+

Published Research Related to This Trial

A group education class on lung cancer screening significantly improved participants' knowledge, with an average increase of 0.9 correct responses on a true-false quiz after the class, based on surveys from 680 participants.

Approximately 70% of participants felt they had enough information to make informed decisions about lung cancer screening after attending the class, indicating that this educational approach effectively enhances decision-making capacity.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Effectiveness of a Patient Education Class to Enhance Knowledge about Lung Cancer Screening: a Quality Improvement Evaluation. Sakoda, LC., Meyer, MA., Chawla, N., et al.[2021]

Four new scales were developed to measure health beliefs about lung cancer screening in long-term smokers, focusing on perceived risk, benefits, barriers, and self-efficacy, with input from experts and smokers.

Psychometric testing of these scales with 497 long-term smokers showed high reliability (Cronbach's α ranging from .88 to .92) and validity, indicating they can effectively identify smokers more likely to participate in lung cancer screening and inform future interventions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Development and Psychometric Evaluation of the Lung Cancer Screening Health Belief Scales. Carter-Harris, L., Slaven, JE., Monohan, P., et al.[2018]

The NHS England leaflet for the Targeted Lung Health Check (TLHC) program was generally well-received by 40 current and former smokers aged 55-73, helping them understand the screening process and fostering positive intentions towards participation.

Participants expressed anxiety about potential screening results but felt reassured by the involvement of healthcare professionals; however, they struggled with understanding certain risks and eligibility criteria, indicating a need for clearer communication to support informed decision-making.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study. Jallow, M., Black, G., van Os, S., et al.[2022]

In a study of 995 patients undergoing lung cancer screening with low-dose computed tomography (LDCT), 2.9% were diagnosed with lung cancer, indicating that screening can lead to early detection in a predominantly African American population.

The screening had a false-positive rate of 9.4%, with very few complications (0.7% from false-positive procedures), highlighting that while harms are rare, they need to be communicated effectively to patients, especially in underserved communities.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Lung Cancer Screening in a Safety-Net Hospital: Rare Harms Inform Decision Making. Lutzow, LK., Magarinos, J., Dass, C., et al.[2022]

The Risk-Based NLST Outcomes Tool (RNOT) helps individuals understand their personalized risk of lung cancer diagnosis and death, which can aid in making informed decisions about screening.

Participants in the study found the RNOT useful for screening decisions, although they expressed confusion about risk changes and indicated that there was no level of false-positive risk that would deter them from screening.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Patient Perspectives on the Risk-Based NLST Outcomes Tool for Lung Cancer Screening. Roberts, MC., Seaman, EL., Klein, WMP., et al.[2022]

A computer-tailored decision support tool has been developed to help patients engage in shared decision-making about lung cancer screening, with initial phases showing it is user-friendly and satisfactory for participants.

The ongoing pilot randomized controlled trial with 60 participants aims to assess the tool's effectiveness in improving knowledge, perceived risk, and self-efficacy regarding lung cancer screening, which could lead to better patient-clinician discussions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Development and Usability Testing of a Computer-Tailored Decision Support Tool for Lung Cancer Screening: Study Protocol. Carter-Harris, L., Comer, RS., Goyal, A., et al.[2020]

In a study of 1,060 adults participating in a lung cancer screening program, it was found that former smokers had a high perception of the effectiveness of screening, with 86.4% considering it beneficial for early disease detection.

The results indicated that both smokers and former smokers participated in lung screening at higher rates than non-smokers, suggesting that targeted communication strategies from general practitioners could further enhance participation among smokers.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

First result of differentiated communication--to smokers and non-smokers--in order to increase the voluntary participation rate in lung screening. Moizs, M., Bajzik, G., Lelovics, Z., et al.[2021]

Lung cancer screening using low-dose chest CT scans can significantly reduce lung cancer mortality in a very high-risk group, highlighting its efficacy as a preventive measure.

Successful implementation of lung cancer screening programs requires addressing 11 identified obstacles, emphasizing the need for a multi-disciplinary approach and viewing screening as a comprehensive program rather than just a single test.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Obstacles to and Solutions for a Successful Lung Cancer Screening Program. Mazzone, PJ.[2018]

Only 11% of reviewed NCI-Designated Cancer Center websites offered online lung cancer screening assessments, but most of these provided tailored recommendations based on national guidelines for lung cancer screening eligibility.

While the assessments encouraged patients to discuss their results with healthcare providers and highlighted the importance of a tobacco-free lifestyle, there is a need for more support to help patients effectively engage in shared decision-making conversations with their doctors.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Assessment of Lung Cancer Screening Eligibility on NCI-Designated Cancer Center Websites. Paige, SR., Salloum, RG., Carter-Harris, L.[2022]

A randomized controlled trial is being conducted to evaluate the effectiveness of a social media-based intervention called LungTalk, aimed at increasing awareness and knowledge about lung cancer screening among high-risk individuals.

The study addresses the low uptake of lung cancer screening despite evidence from the National Lung Screening Trial showing that low-dose computed tomography can reduce lung cancer mortality, highlighting the potential of social media to reach underserved populations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Leveraging social media to increase lung cancer screening awareness, knowledge and uptake among high-risk populations (The INSPIRE-Lung Study): Study protocol of design and methods of a community-based randomized controlled trial. Lisa, CB., Banerjee, SC., Ostroff, JS., et al.[2023]

The National Lung Screening Trial found that annual low-dose CT scans can reduce lung cancer-specific mortality by 20% in older heavy smokers, highlighting the potential effectiveness of lung cancer screening.

To maximize the benefits of lung cancer screening, ongoing research is essential for improving risk assessment, patient communication, and management of detected abnormalities, ensuring that screening programs are implemented responsibly.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Lung cancer screening. Arenberg, D.[2015]

A decentralized lung cancer screening program was successfully implemented across five primary care offices over three years, increasing access to screenings for patients in northeast Florida.

The program led to a higher percentage of early-stage lung cancers being detected, which significantly improved patient outcomes and survival rates.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Lung Cancer Screening: Development and Replication of a Decentralized Program to Increase Access. Austin, C.[2021]

In a study involving 51 patients undergoing lung cancer screening, participants expressed high satisfaction with the information provided by clinicians, despite recalling few specific harms or benefits of the screening.

Patients reported a strong sense of trust in their clinicians and were generally satisfied with their role in the decision-making process, even though the communication did not fully align with the ideal of shared decision-making.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

"I'm Putting My Trust in Their Hands": A Qualitative Study of Patients' Views on Clinician Initial Communication About Lung Cancer Screening. Golden, SE., Ono, SS., Thakurta, SG., et al.[2021]

Citations

1.

sciencedirect.com

sciencedirect.com/science/article/pii/S2666364323001285

A Brief Report Case Study Using the Lung Cancer Stigma ...

The INSPIRE-Lung Study uses a computer-tailored health communication and decision support tool called LungTalk (#NCT05824273). The overarching communication ...

2.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC7671845/

Computer-Tailored Decision Support Tool for Lung Cancer ...

LungTalk is a computer-tailored decision support tool that is theoretically grounded in the Conceptual Model on Lung Cancer Screening ...

3.

withpower.com

withpower.com/trial/phase-lung-neoplasms-5-2023-36bde

LungTalk for Increasing Lung Cancer Screening

These findings imply that similar tools, such as LungTalk, may also be effective in increasing lung cancer screening by facilitating better communication and ...

4.

nlcrt.org

nlcrt.org/resource/effective-communication-about-lung-cancer-screening-without-iatrogenic-stigma-a-brief-report-case-study-using-the-lung-cancer-stigma-communications-assessment-tool-of-lungtalk/

A Brief Report Case Study Using the Lung Cancer Stigma ...

Effective Communication About Lung Cancer Screening Without Iatrogenic ... Lung Cancer Stigma Communications Assessment Tool of LungTalk. Effective ...

5.

cancernetwork.com

cancernetwork.com/view/combatting-stigmatization-to-increase-lung-cancer-screening-access

Combatting Stigmatization to Increase Lung Cancer ...

According to findings published in JTO Clinical Research and Reports, applying the Lung Cancer Stigma Communications Assessment Tool to LungTalk ...

6.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC10223838/

Leveraging social media to increase lung cancer screening ...

Early health communication tools and decision aids for lung screening have ... communication and decision support intervention related to lung screening (LungTalk) ...

7.

clinicaltrials.gov

clinicaltrials.gov/study/NCT05824273

Study Details | NCT05824273 | The INSPIRE-Lung Study

LungTalk is a 10-15 minute long computer-tailored health communication and decision-making tool that is theoretically grounded in the Conceptual Model on Lung ...

8.

mdpi.com

mdpi.com/1660-4601/22/8/1250

Effectiveness of Technology-Based Interventions in ...

... technology-based tools aiming to increase lung cancer screening uptake. ... Tool for Lung Cancer Screening: Community-Based Pilot Randomized Controlled Trial.